Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer
Aram Safrastyan1,2, Christian Höner Zu Siederdissen3, Damian Wollny4,5,6
1RNA Bioinformatics and High Throughput Analysis, Friedrich Schiller University Jena, Jena, Germany. aram.safrastyan@uni-jena.de.
Human Genomics
|October 5, 2023
Summary
Cell-free RNA (cfRNA) analysis in liquid biopsies reveals increased hepatocyte proportions in liver cancer patients. This finding aids in distinguishing cancer from healthy samples, enhancing diagnostic strategies.
Area of Science:
- Biochemistry
- Genomics
- Oncology
Background:
- Liquid biopsy, utilizing cell-free RNA (cfRNA), is a promising non-invasive tool for disease diagnostics, particularly cancer.
- Understanding cfRNA composition and cellular origin in blood is crucial for identifying tissue alterations during carcinogenesis.
- Further research is needed to confirm the consistency and clinical utility of cfRNA findings.
Purpose of the Study:
- To investigate cell type contributions to the cfRNA transcriptomic landscape in liver cancer.
- To assess the utility of cfRNA cellular proportions for classifying cancer versus healthy samples.
- To compare the diagnostic performance of cfRNA proportions with established biomarkers.
Main Methods:
- Analysis of over 350 blood samples from four distinct studies.
- Investigated cell type contributions to the cfRNA transcriptomic landscape.
- Utilized cellular deconvolution techniques to analyze cfRNA composition.
Main Results:
- An increased proportion of hepatocytes in blood cfRNA was a consistent finding across studies, enabling effective classification of liver cancer.
- Liver endothelial cell signatures were also prominent in cfRNA alterations.
- Cellular proportions demonstrated comparable or enhanced classification performance when compared to existing markers.
Conclusions:
- Changes in liver cell-type composition in blood cfRNA robustly aid in classifying liver cancer from healthy samples, despite dataset heterogeneity.
- Integrative and comparative approaches are vital for future research to ensure robustness of findings.
- This study highlights the potential of cellular deconvolution in liquid biopsy for understanding cfRNA in liver cancer.
Related Concept Videos
01:58Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:30General Transcription Factors
5.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
02:16Transcription Factors
76.0K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
76.0K